ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
Closed while relocating
1300 128 339
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Vitamin D may be of help in Fibromyalgia
Tuesday 22 May 2012
GLASGOW -- Only 15% of fibromyalgia patients in a small study had adequate levels of vitamin D, suggesting implications for treatment.
Among a cohort of 36 patients, 28% had levels of serum 25-hydroxy vitamin D that were considered deficient, defined as below 25 nmol/L, according to Sekharipuram A. Ramakrishnan, MD, of Our Lady's Hospital in Navan, Ireland.
And 62% of the cohort had levels considered insufficient, between 25 and 80 nmol/L, he reported in a poster session at the annual meeting of the British Society for Rheumatology.
Previous studies examining the relationship between vitamin D levels and nonspecific musculoskeletal pain have turned in conflicting results.
In some cohorts of patients with fibromyalgia, vitamin D levels were low, while in other groups there were no differences between patients and controls.
Moreover, in some studies, patients with low levels who received supplementation with the vitamin showed no clinical benefit.
"Nonetheless, we do know that vitamin D deficiency is associated with muscle pain, which is why we did this observational study," Ramakrishnan told MedPage Today.
Patients' mean age was 47, and 90% were women.
Serum calcium and alkaline phosphatase levels were normal in all patients, indicating normal bone chemistry.
The study findings must be considered in light of the background population, however, Ramakrishnan said.
"Ireland is not very sunny, and 30% to 40% of all Irish women are deficient in vitamin D," he explained. "We postulate that these patients are staying indoors because of their pain, and aren't inclined to go on holidays in sunny locations because of their disability."
Further work is needed to determine if early detection and replacement of vitamin D may have a therapeutic role in the overall management of fibromyalgia. Therefore, large scale studies of this should be undertaken, Ramakrishnan said.
"We are currently giving all our fibromyalgia patients vitamin D supplements," he added.
The authors had no conflicts of interest.
Primary source: British Society for Rheumatology
The above, with comments, originally appeared here.
blog comments powered by Disqus